Hvorfor velge oss? Tradisjonell varehandel står ovenfor store utfordringer i konkurranse med veksten i netthandel. Spesielt presserende er utfordringer i forhold til kjøpsopplevelse, effektivitet og lønnsomhet. ​ Vårt fokus i Qtime er å hjelpe varehandelen til å løse nettopp disse utfordringene. Gi kundene dine den beste handleopplevelsen, med fremtidens kundestrømsverktøy.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

BioPlan optimizes production planning for all steps in the aquaculture value chain, from roe to harvest.BioPlan's algorithms represent the state-of-the-art in production optimization. They are the result of many years of in-depth research and development, both in-house and at the Norwegian University of Science and Technology in Trondheim, Norway. BioPlan is today used for planning salmon production with an annual sales value of 4 billion NOKOfficial launched of software in August 2017. Now building a customer base

AURA Biopharm AS was founded in 2016 by a team of scientists and drug developers with many years of experience in academia and major pharmaceutical companies and a proven track record of success in drug development. The emphasis of AURA is the development of novel and breakthrough therapies for unmet medical needs and orphan diseases and our slogan “A new opportunity for health” reflects AURA's mission to give a new opportunity to diseases in need of new and/or better therapies. The company operates virtually using a network of external collaborators (consultants, KOLs, CROs, CMOs etc).

We start our project in 2017. We develop and offer to the market ecological & sustainable fertilizers made by mineral and organic nature. We cultivate a unique product and engage experience and innovation. By offering a quality product with added value to our customers, we help make a cost-effective solution for horticulture and agriculture.  We are happy to be engaged in the optimization of performance for allied businesses and private customers.

Five seasoned experts with over 175 years of experience in the oil & gas industry have developed a new patent pending disruptive revolutionary technology.   Water is separated in a horizontal well bore close to the reservoir and thereafter re-injected via a lateral well as pressure support to increase oil recovery. The Fluidsep DPP combines production and injection in one well with no spill to the surface, all excess water and sand is re-injected and never sees the surfaceThe technology enables  35% extra oil production and at the same time results in significantly reduced CO2/barrel of Oil. More than a 30% reduction compared with conventional production. An example of simulations shows extra income of > 1 Billion NOK per well. Fluidsep DPP has achieved TRL 2 - and requires 2 years of qualifications and pilot testing to be ready for the market, TRL 7. Strong interest in the market about our technology. Currently inviting investors and Seed capital funds to participate in the joint development of building a new international downhole service provider based in the Bergen region.

Building a "børs"  for the worlds non for profit organisation in Oslo. Oslo Philanthropic Exchange is a non-profit foundation. Our mission is to bring the best practice from the global capital markets to raise philanthropic funding more efficiently. Our goal is to contribute to higher impact of philanthropic capital. The OPX Solution addresses the inefficient funding of the non-profit sector and the lack of standardised, transparent and comparable data. By applying best practice from the capital markets for listing of non-profit organisations and reporting requirements as well as leveraging existing infrastructures, we standardise and digitalise to increase efficiency, transparency, accountability and accessibility. The OPX Solution represent the complete value chain of finding, filtering, funding and following the world’s non-profit organisations.

Momentum Technologies is a specialist company with a focus on preventing stress and fatigue in vital equipment and structures in the oil and gas industry. Fatigue in oil and gas leading pipes can lead to fire and explosions and may cause large-scale accidents. Through unique expert services and solutions within vibration and sound, Momentum Technologies provides fatigue prevention. Momentum Technologies’ core competency is in the understanding of the underlying physics of vibrations. We break down the problem, make it understandable, and provide targeted and cost-efficient solutions.

Pridok AS er et Horten basert softwarefirma som har utviklet et nytt og moderne skybasert elektronisk pasientjournalsystem, Pridok EPJ på Microsoft Azure plattformen. Vi har tatt utgangspunkt i Helsedirektoratets kravspesifikasjon og lagt til ytterligere krav som vi har kartlagt.Pasientsikkerhet og kvalitetsikring av behandlingen er et stort fokusområde i Pridok EPJ. Nå kan legen for første gang bruke en EPJ-løsning uavhengig av plattform, enhet og som gir full mobilitet.Vi lar leger være leger uten at de må bruke tid på VPN, backup, servere etc.Flere hundre leger har forhåndsregistrert seg for løsningen vår som går i pilot våren 2017.

OK, Self-Storage Group consists of the brand's City Self-Storage and OK Minilager. We have more than 60 locations in Scandinavia. We aspire to be the leading company in tech in our industry. We have just closed funding from several investors, and we have an ambitious growth plan for the years to come.

Exabel is an artificial intelligence startup based in Oslo, Norway. Exabel’s mission is to synthesize the world’s information and learn how it evolves. We are developing a smart digital assistant software tool for professional investment managers. We are currently a team of 6 full-time employees, with diverse backgrounds; two mathematicians, three software engineers, and a business developer. Combined, we have strong experience with companies like Google, Medallia, Arctic Securities, Intelligent Trading, Microsoft, and Brain Corporation. We are located in Forskningsparken, by StartupLab. The company is well funded for several years of research, product development, and market launch.

Korall Engineering AS is a design engineering firm part of StartupLab Bergen, a member of the GCE Ocean Technology Cluster, which employs the latest high-end design optimization technologies, our team develops automates product design workflows to reduce engineering and lead times and redesigns existing industrial products. Through the use of Artificial Intelligence, we help reduce material waste and production costs, increase efficiency, and lessen environmental impact. We help the reduction of carbon emissions, avoiding the transportation of parts demanded. Korall Engineering operates in various industries: oil & gas, maritime, automotive, and medical. Its team specializes in industrial design optimization for both additive and traditional manufacturing and uses machine learning design-to-manufacturing tools like Generative Design, mathematical finite element methods like Topology Optimization, and implicit modeling lattice-structure solutions for 3D-printing, both for metal and composite materials. Korall Engineering is betting on the future: smart design, additive manufacturing, and automated workflows are just a few of the many examples of how it is possible to disrupt the industry for the better, bring innovation, create value for our society at large, and tangibly take a step forward in preserving our environment. For more information visit https://korall.io/

With our breakthrough apps we are changing how the e-commerce industry captures and publishes images. Autopix puts the photo studio in the pocket of users making the publishing process more efficient and user friendly. With our smartphone technology you no longer need to hire expensive photographers. Simply allow our photo guide to help you take professional photos at a fraction of the cost. We are an ambitious team, focused on building user friendly and efficient tools with expected revenue between 11-13 MNok in 2021. We currently work in close collaboration with some of the biggest names in Norway, which include - Varner Group, XXL, Holzweiler, Høyer, Tradesolution, and many other well-known companies. Our offices are at Startup Lab in Oslo’s Science Park, one of the leading tech hubs in Scandinavia.

Pretty miserable out there, isn’t it? We’re in the business of spreading smiles. Glede is a micro gifting platform that enables users to send gifts to friends, family, and co-workers. Through Glede you can send everything from a cup of coffee to a bouquet of flowers, or an experience. Glede makes the sending and receiving of gifts spontaneous, fun, and easy!

Songpark shall be the "Worldwide preferred solution for online musical collaboration!" Songpark is an Oslo-based company founded in 2018 by musician and computer technician Christian Ruud. The company has grown fast and is now the "most promising creative-tech startup in Norway". Musicians and investors all believe in our vision: To create an online musical community and to make it possible to play together at a distance. We are developing a solution (HW+SW) enabling musicians to play together online in real time at disparate locations. Our solution has been tested between different locations for up to 500 km. – and it works!